Detalles de la búsqueda
1.
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline-trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial.
Lancet;
403(10422): 160-170, 2024 Jan 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38104575
2.
Psychosis superspectrum II: neurobiology, treatment, and implications.
Mol Psychiatry;
2024 Feb 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38351173
3.
Elexacaftor/Tezacaftor/Ivacaftor Treatment and Depression-related Events.
Am J Respir Crit Care Med;
209(3): 299-306, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37890129
4.
Severe mental illness: cardiovascular risk assessment and management.
Eur Heart J;
45(12): 987-997, 2024 Mar 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38538149
5.
Relapse Rates With Paliperidone Palmitate in Adult Patients With Schizophrenia: Results for the 6-Month Formulation From an Open-label Extension Study Compared to Real-World Data for the 1-Month and 3-Month Formulations.
Int J Neuropsychopharmacol;
27(2)2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38300235
6.
What is the duration of untreated psychosis worldwide? - A meta-analysis of pooled mean and median time and regional trends and other correlates across 369 studies.
Psychol Med;
54(4): 652-662, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38087871
7.
Prediction of estimated risk for bipolar disorder using machine learning and structural MRI features.
Psychol Med;
54(2): 278-288, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37212052
8.
Self-stigma in schizophrenia: a systematic review and meta-analysis of 37 studies from 25 high- and low-to-middle income countries.
Mol Psychiatry;
28(5): 1920-1931, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36890299
9.
Efficacy and acceptability of psychosocial interventions in schizophrenia: systematic overview and quality appraisal of the meta-analytic evidence.
Mol Psychiatry;
28(1): 354-368, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35999275
10.
Incidence, prevalence, and global burden of schizophrenia - data, with critical appraisal, from the Global Burden of Disease (GBD) 2019.
Mol Psychiatry;
2023 Jul 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37500825
11.
Pharmacological interventions for antipsychotic-related sialorrhea: a systematic review and network meta-analysis of randomized trials.
Mol Psychiatry;
28(9): 3648-3660, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37821573
12.
An umbrella review of candidate predictors of response, remission, recovery, and relapse across mental disorders.
Mol Psychiatry;
28(9): 3671-3687, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37957292
13.
The impact of pharmacological and non-pharmacological interventions on physical health outcomes in people with mood disorders across the lifespan: An umbrella review of the evidence from randomised controlled trials.
Mol Psychiatry;
28(1): 369-390, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36138129
14.
Towards a youth mental health paradigm: a perspective and roadmap.
Mol Psychiatry;
28(8): 3171-3181, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37580524
15.
Comparing family-based treatment with inpatient treatment in youth with anorexia nervosa eligible for hospitalization: A 12-month feasibility study.
Int J Eat Disord;
57(2): 388-399, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38082440
16.
Premorbid body weight predicts weight loss in both anorexia nervosa and atypical anorexia nervosa: Further support for a single underlying disorder.
Int J Eat Disord;
57(4): 967-982, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38528714
17.
[Efficacy of internet-based interventions for depression available in Germany-A systematic review and meta-analysis]. / Wirksamkeit in Deutschland verfügbarer internetbasierter Interventionen für Depressionen ein systematisches Review mit Metaanalyse.
Nervenarzt;
95(3): 206-215, 2024 Mar.
Artículo
en Alemán
| MEDLINE | ID: mdl-38260995
18.
Association of severe mental illness and septic shock case fatality rate in patients admitted to the intensive care unit: A national population-based cohort study.
PLoS Med;
20(3): e1004202, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36913434
19.
Emraclidine, a novel positive allosteric modulator of cholinergic M4 receptors, for the treatment of schizophrenia: a two-part, randomised, double-blind, placebo-controlled, phase 1b trial.
Lancet;
400(10369): 2210-2220, 2022 12 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36528376
20.
New Developments in the Treatment of Schizophrenia: An Expert Roundtable.
Int J Neuropsychopharmacol;
26(5): 322-330, 2023 05 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-36932673